What is BLONDER TONGUE LABS INC's earnings per share (EPS)?

BLONDER TONGUE LABS INC (BDRL) reported diluted earnings per share of -$0.22 for fiscal year 2022. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

BLONDER TONGUE LABS INC (BDRL) Financials

BDRL

FY2022 annual

Revenue $18.1M +15.0% YoY

Net Income -$2.9M -3576.2% YoY

EPS (Diluted) -$0.22 YoY not available

Operating Cash Flow -$1.4M -18.4% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2022, ended Dec 31, 2022 Reported Apr 17, 2023 Currency USD FYE December

Newest figures come from the 10-K for FY2022, filed Apr 17, 2023. Each column of the statement tables below links to the filing it was taken from.

BLONDER TONGUE LABS INC (BDRL) reported $18.1M in revenue for fiscal year 2022, up 15.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BDRL FY2022 2026-10-03

Blonder Tongue’s latest figures show a shrinking equity cushion, persistent cash outflows, and dependence on financing despite partial margin recovery.

Gross margin fell from 37.2% in FY2021 to 30.2% in FY2022, so the improved operating margin did not come from stronger gross economics. Operating margin improved from -18.8% to -11.8%, but the company still produced a net loss and negative operating cash flow, showing that cost reductions were insufficient to make operations self-funding.

The balance sheet became materially more fragile: the current ratio slipped to 1.0x, while the debt-to-equity ratio reached 13.0x. With liabilities approaching the asset base, modest operating setbacks have a larger effect on the remaining equity cushion.

Operating cash flow was -$1.4M in FY2022, while financing supplied $1.2M; external financing offset operating cash needs rather than internally generated cash. The reported liquidity comparison was only 0.7 months of the latest annual operating outflow, reinforcing the company’s reliance on financing capacity.

Financial Health Signals

Financial health score not available

BLONDER TONGUE LABS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-2.09

BLONDER TONGUE LABS INC scores -2.09, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($260K) relative to total liabilities ($13.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

1/8

BLONDER TONGUE LABS INC passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

BLONDER TONGUE LABS INC reported a net loss of $2.9M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

BLONDER TONGUE LABS INC reported an operating loss of $2.1M against $789K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.3M

YoY+32.2%

QoQ+0.3%

5Y CAGR-1.1%

10Y CAGR-3.7%

BLONDER TONGUE LABS INC generated $5.3M in revenue in Q4 2022. This represents an increase of 32.2% from the same quarter a year earlier. Against the prior quarter it is up 0.3%.

Net Income

$90K

YoY+109.7%

QoQ+112.8%

5Y CAGR-18.9%

BLONDER TONGUE LABS INC reported $90K in net income in Q4 2022. This represents an increase of 109.7% from the same quarter a year earlier. Against the prior quarter it is up 112.8%.

EPS (Diluted)

$0.01

BLONDER TONGUE LABS INC earned $0.01 per diluted share (EPS) in Q4 2022.

EBITDA

Not reported for Q4 2022.

Cash & Balance Sheet

Cash & Debt

$79K

YoY-71.2%

QoQ-52.7%

5Y CAGR-14.0%

10Y CAGR-16.0%

BLONDER TONGUE LABS INC held $79K in cash as of Q4 2022; long-term debt is not reported for that period.

Shares Outstanding

13M

5Y CAGR+10.2%

10Y CAGR+8.0%

BLONDER TONGUE LABS INC had 13M shares outstanding in Q4 2022.

Free Cash Flow

Not reported for Q4 2022.

Dividends Per Share

Not reported for Q4 2022.

Margins & Returns

Gross Margin

39.0%

YoY+4.7pp

QoQ+12.2pp

5Y change-1.1pp

10Y change+10.6pp

BLONDER TONGUE LABS INC's gross margin was 39.0% in Q4 2022, indicating the percentage of revenue retained after direct costs. This is up 4.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.2 percentage points.

Net Margin

1.7%

YoY+24.9pp

QoQ+15.1pp

5Y change-2.9pp

10Y change+43.0pp

BLONDER TONGUE LABS INC's net profit margin was 1.7% in Q4 2022, showing the share of revenue converted to profit. This is up 24.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.1 percentage points.

Return on Equity

8.4%

YoY+36.6pp

QoQ+83.4pp

5Y change+4.9pp

10Y change+27.5pp

BLONDER TONGUE LABS INC's ROE was 8.4% in Q4 2022, measuring profit generated per dollar of shareholder equity. This is up 36.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 83.4 percentage points.

Operating Margin

Not reported for Q4 2022.

Capital Allocation

R&D Spending

$357K

YoY-46.8%

QoQ-6.5%

5Y CAGR-9.1%

10Y CAGR-8.3%

BLONDER TONGUE LABS INC invested $357K in research and development in Q4 2022. This represents a decrease of 46.8% from the same quarter a year earlier. Against the prior quarter it is down 6.5%.

Share Buybacks

Not reported for Q4 2022.

Capital Expenditures

Not reported for Q4 2022.

BDRL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BDRL quarterly income statement

Metric	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$18.1M+15.0%	$15.8M-3.8%	$16.4M-17.5%	$19.8M-8.6%	$21.7M-6.8%	$23.3M+3.5%	$22.5M+7.5%	$20.9M-28.1%	$29.1M+4.5%	$27.9M-9.0%	$30.6M+14.9%	$26.7M-12.6%	$30.5M
Cost of Revenue	$40K-4.8%	$42K-99.7%	$13.4M-18.6%	$16.4M+23.5%	$13.3M-7.4%	$14.3M+1.4%	$14.1M-15.7%	$16.8M-7.6%	$18.2M-2.1%	$18.6M-10.0%	$20.6M+20.5%	$17.1M-6.1%	$18.2M
Gross Profit	$5.5M-6.7%	$5.9M+94.1%	$3.0M-12.0%	$3.4M-59.2%	$8.4M-5.8%	$8.9M+6.9%	$8.4M+101.1%	$4.2M-62.1%	$11.0M+17.7%	$9.3M-7.1%	$10.0M+5.0%	$9.5M-22.2%	$12.3M
R&D Expenses	$1.8M-31.4%	$2.6M+2.7%	$2.5M-17.7%	$3.1M+19.0%	$2.6M+5.1%	$2.5M-10.5%	$2.7M-17.7%	$3.3M-2.5%	$3.4M+1.3%	$3.4M-3.6%	$3.5M+28.9%	$2.7M+8.3%	$2.5M
SG&A Expenses	$3.8M+1.4%	$3.8M-26.9%	$5.2M+2.9%	$5.0M+18.1%	$4.2M+20.0%	$3.5M-7.8%	$3.8M-7.8%	$4.2M-13.0%	$4.8M-6.7%	$5.1M-9.3%	$5.6M+27.8%	$4.4M-4.1%	$4.6M
Operating Income	-$2.1M+28.0%	-$3.0M+58.4%	-$7.1M-1426.6%	-$466K+45.4%	-$854K-284.4%	$463K+169.0%	-$671K+89.5%	-$6.4M-917.5%	-$629K+75.3%	-$2.5M-2.0%	-$2.5M-966.2%	-$234K-111.8%	$2.0M
EBITDA	-$2.0M+28.7%	-$2.9M+59.2%	-$7.0M-5537.0%	-$124K+66.6%	-$371K-138.8%	$955K+1691.7%	-$60K+99.0%	-$5.7M-6843.5%	$85K+104.6%	-$1.8M-4.6%	-$1.8M-1219.1%	$157K-93.3%	$2.3M
Interest Expense	$789K+53.5%	$514K+49.0%	$345K+32.2%	$261K-53.6%	$562K-22.3%	$723K+75.5%	$412K+26.8%	$325K+34.3%	$242K-12.6%	$277K-16.1%	$330K+80.3%	$183K-8.0%	$199K
Income Tax	N/A	$15K0.0%	$15K0.0%	$15K+119.5%	-$77K-327.8%	-$18K-162.1%	$29K-37.0%	$46K+48.4%	$31K	$0-100.0%	$2.3M	$0	$0
Net Income	-$2.9M-3576.2%	$84K+101.1%	-$7.5M-907.3%	-$742K+44.6%	-$1.3M-248.7%	-$384K+67.9%	-$1.2M+82.4%	-$6.8M-650.7%	-$902K+68.0%	-$2.8M+45.3%	-$5.2M-1154.7%	-$411K-123.0%	$1.8M
EPS (Basic)	-$0.22-2300.0%	$0.01+101.3%	-$0.76	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.07-124.1%	$0.29
EPS (Diluted)	-$0.22	$0.02	-$0.76	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.07-125.0%	$0.28
Diluted Shares (Avg)	13,281	15,450	10M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	6,216-99.9%	6M-1.2%	6M

Metric	Q4'2210-K	Q3'2210-Q	Q2'2210-Q	Q1'2210-Q	Q4'2110-K	Q3'2110-Q	Q2'2110-Q	Q1'2110-Q
Revenue	$5.3M+32.2%	$5.3M+26.1%	$4.2M-2.4%	$3.3M+2.8%	$4.0M-7.7%	$4.2M0.0%	$4.3M+13.2%	$3.3M-19.7%
Cost of Revenue	-$9.4M-29.9%	$3.9M+44.2%	$3.2M+16.1%	$2.4M+28.7%	-$7.2M-288.7%	$2.7M-22.2%	$2.7M+5.3%	$1.9M-46.6%
Gross Profit	$2.1M+50.2%	$1.4M-6.1%	$1.1M-34.0%	$939K-32.2%	$1.4M+176.6%	$1.5M+103.9%	$1.6M+30.0%	$1.4M+150.5%
R&D Expenses	$357K-46.8%	$382K-42.1%	$498K-20.1%	$541K-15.2%	$671K+1.8%	$660K+10.0%	$623K+2.5%	$638K-2.9%
SG&A Expenses	$895K+8.7%	$1.0M+13.3%	$993K+2.9%	$913K-15.4%	$823K-48.5%	$900K-25.2%	$965K-16.9%	$1.1M-9.1%
Operating Income	N/A	-$475K+32.4%	-$962K-55.9%	N/A	-$777K+66.3%	-$703K+58.2%	-$617K+44.3%	-$863K+57.3%
EBITDA	N/A	-$453K+32.7%	-$940K-60.7%	N/A	-$762K+66.6%	-$673K+59.1%	-$585K+45.6%	-$830K+58.2%
Interest Expense	$236K+74.8%	$228K+94.9%	$192K+43.3%	$133K+3.9%	$135K+45.2%	$117K+11.4%	$134K+55.8%	$128K+109.8%
Net Income	$90K+109.7%	-$703K-249.8%	-$1.2M-170.9%	-$1.2M-178.7%	-$927K+61.6%	-$201K+88.8%	$1.6M+236.2%	-$414K+80.1%
EPS (Basic)	$0.01+114.3%	-$0.05-150.0%	-$0.09-164.3%	N/A	-$0.07+70.8%	-$0.02+88.9%	$0.14+216.7%	N/A
EPS (Diluted)	$0.01	-$0.05-150.0%	-$0.09-181.8%	-$0.09-125.0%	-$0.06	-$0.02+88.9%	$0.11+191.7%	-$0.04+81.0%
Diluted Shares (Avg)	N/A	13M+9.0%	13,317-12.7%	13M+12.7%	N/A	12M+125035.6%	15,254+56.2%	12M+19.3%

Not reported in any period shown, so not listed: Income Tax.

BDRL Balance Sheet

BDRL quarterly balance sheet

Metric	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$15.0M+26.0%	$11.9M+7.0%	$11.1M-39.3%	$18.3M+17.6%	$15.6M+2.8%	$15.2M+1.2%	$15.0M-7.6%	$16.2M-23.6%	$21.2M-6.2%	$22.6M-13.9%	$26.3M+1.7%	$25.9M-2.8%	$26.6M
Current Assets	$8.0M+3.8%	$7.7M+25.8%	$6.1M-49.9%	$12.2M+17.3%	$10.4M+15.9%	$8.9M+10.8%	$8.1M-2.8%	$8.3M-33.8%	$12.6M-4.5%	$13.2M-17.5%	$16.0M+16.6%	$13.7M-1.4%	$13.9M
Cash & Equivalents	$79K-71.2%	$274K+297.1%	$69K-87.9%	$572K+2.3%	$559K+232.7%	$168K-64.1%	$468K+5100.0%	$9K-96.1%	$232K+246.3%	$67K-85.2%	$453K-46.8%	$851K-50.4%	$1.7M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$4.0M-18.3%	$4.9M+19.5%	$4.1M-52.1%	$8.5M+37.5%	$6.2M+12.3%	$5.5M+8.5%	$5.1M-9.5%	$5.6M-39.6%	$9.3M+3.1%	$9.0M-20.7%	$11.3M+49.6%	$7.6M-1.4%	$7.7M
Accounts Receivable	$3.4M+92.0%	$1.8M+1.4%	$1.7M-30.5%	$2.5M-5.6%	$2.7M+1.3%	$2.6M+15.3%	$2.3M-6.5%	$2.4M+0.3%	$2.4M-25.2%	$3.2M-6.4%	$3.5M-22.8%	$4.5M+22.0%	$3.7M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K	$0	N/A
Total Liabilities	$13.9M+61.5%	$8.6M-12.8%	$9.9M-9.9%	$11.0M+30.2%	$8.4M+8.7%	$7.8M-8.3%	$8.5M-4.5%	$8.9M+18.1%	$7.5M-1.4%	$7.6M-21.3%	$9.7M+107.3%	$4.7M+2.2%	$4.6M
Current Liabilities	$8.2M+34.6%	$6.1M+9.5%	$5.5M-33.9%	$8.4M+1.3%	$8.3M+109.8%	$3.9M-14.7%	$4.6M-46.5%	$8.6M+126.7%	$3.8M+4.0%	$3.7M-33.3%	$5.5M+197.0%	$1.8M+8.8%	$1.7M
Non-Current Liabilities	$5.8M+125.2%	$2.6M-41.2%	$4.4M+66.7%	$2.6M+1429.2%	$171K-95.5%	$3.8M-0.7%	$3.9M+1510.9%	$239K-93.5%	$3.7M-6.4%	$4.0M-5.7%	$4.2M+48.6%	$2.8M-1.8%	$2.9M
Long-Term Debt	N/A	N/A	$1.8M+3723.4%	$47K+46.9%	$32K-99.0%	$3.1M-7.2%	$3.3M+33250.0%	$10K-99.7%	$3.6M-7.3%	$3.9M-6.5%	$4.2M+47.6%	$2.8M-1.8%	$2.9M
Total Equity	$1.1M-67.3%	$3.3M+165.6%	$1.2M-83.2%	$7.4M+2.7%	$7.2M-3.3%	$7.4M+13.5%	$6.5M-11.3%	$7.4M-46.4%	$13.7M-8.6%	$15.0M-9.6%	$16.6M-21.6%	$21.2M-3.8%	$22.0M
Retained Earnings	-$30.2M-10.7%	-$27.3M+0.3%	-$27.4M-37.5%	-$19.9M-3.9%	-$19.2M-7.6%	-$17.8M-3.7%	-$17.2M-40.8%	-$12.2M-197.8%	-$4.1M-28.2%	-$3.2M-758.6%	-$372K-107.8%	$4.8M-7.9%	$5.2M

Metric	Q4'2210-K	Q3'2210-Q	Q2'2210-Q	Q1'2210-Q	Q4'2110-K	Q3'2110-Q	Q2'2110-Q	Q1'2110-Q
Total Assets	$15.0M+26.0%	$15.3M+26.0%	$12.3M+3.3%	$11.5M+3.7%	$11.9M+7.0%	$12.1M-10.4%	$11.9M-28.4%	$11.1M-33.2%
Current Assets	$8.0M+3.8%	$8.2M+7.8%	$8.6M+20.7%	$7.5M+18.6%	$7.7M+25.8%	$7.6M-6.9%	$7.1M-35.0%	$6.4M-40.8%
Cash & Equivalents	$79K-71.2%	$167K-38.4%	$361K+4.9%	$110K+96.4%	$274K+297.1%	$271K+261.3%	$344K-26.0%	$56K-29.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$4.0M-18.3%	$4.2M+1.9%	$5.0M+31.5%	$5.0M+22.9%	$4.9M+19.5%	$4.1M-22.1%	$3.8M-47.6%	$4.0M-47.2%
Accounts Receivable	$3.4M+92.0%	$3.2M+78.1%	$2.5M+35.0%	$1.4M+29.0%	$1.8M+1.4%	$1.8M-11.9%	$1.8M-21.3%	$1.1M-50.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%	$493K0.0%
Total Liabilities	$13.9M+61.5%	$14.3M+71.2%	$10.8M+28.6%	$9.1M-5.1%	$8.6M-12.8%	$8.4M-23.3%	$8.4M-31.7%	$9.6M-14.5%
Current Liabilities	$8.2M+34.6%	$8.5M+50.1%	$8.7M+57.5%	$6.8M+36.8%	$6.1M+9.5%	$5.6M-9.1%	$5.5M-25.8%	$5.0M-43.7%
Non-Current Liabilities	$5.8M+125.2%	$5.9M+114.9%	$2.1M-26.2%	$2.3M-50.0%	$2.6M-41.2%	$2.7M-42.0%	$2.9M-40.7%	$4.6M+92.7%
Total Equity	$1.1M-67.3%	$937K-75.0%	$1.5M-57.9%	$2.4M+60.2%	$3.3M+165.6%	$3.8M+43.6%	$3.5M-18.8%	$1.5M-72.1%
Retained Earnings	-$30.2M-10.7%	-$30.3M-14.9%	-$29.6M-13.1%	-$28.5M-2.4%	-$27.3M+0.3%	-$26.4M-5.6%	-$26.2M-12.9%	-$27.8M-26.4%

Not reported in any period shown, so not listed: Long-Term Debt.

BDRL Cash Flow Statement

BDRL quarterly cash flow statement

Metric	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	-$1.4M-18.4%	-$1.2M+63.7%	-$3.2M+50.9%	-$6.5M-1213.8%	$587K+347.7%	-$237K-130.7%	$771K+196.6%	-$798K-149.4%	$1.6M-13.2%	$1.9M-48.9%	$3.6M+1423.0%	$239K-92.2%	$3.1M
Depreciation & Amortization	$100K-9.1%	$110K-11.4%	$124K-63.7%	$342K-29.2%	$483K-1.8%	$492K-19.5%	$611K-8.5%	$668K-6.4%	$714K+1.0%	$707K-4.2%	$738K+88.7%	$391K+11.1%	$352K
Stock-Based Compensation	$571K+1.6%	$562K	N/A	$619K+25.6%	$493K+27.7%	$386K+84.7%	$209K-3.2%	$216K-11.8%	$245K-9.9%	$272K+5.4%	$258K+11.7%	$231K+156.7%	$90K
Capital Expenditures	N/A	$31K-81.2%	$165K-37.3%	$263K+224.7%	$81K-41.3%	$138K+273.0%	$37K-80.3%	$188K-72.1%	$673K+337.0%	$154K+51.0%	$102K-49.0%	$200K+70.9%	$117K
Free Cash Flow	N/A	-$1.2M+64.5%	-$3.4M+50.3%	-$6.8M-1444.1%	$506K+234.9%	-$375K-151.1%	$734K+174.4%	-$986K-204.7%	$942K-44.8%	$1.7M-51.8%	$3.5M+8971.8%	$39K-98.7%	$3.0M
Investing Cash Flow	-$55K+36.0%	-$86K+55.0%	-$191K-102.0%	$9.5M+9480.2%	-$101K+49.5%	-$200K	N/A	N/A	N/A	N/A	-$7.6M-767.9%	-$872K+23.5%	-$1.1M
Financing Cash Flow	$1.2M-14.8%	$1.5M-49.7%	$2.9M+199.2%	-$2.9M-2976.8%	-$95K-169.3%	$137K	N/A	N/A	N/A	N/A	$3.5M+1615.0%	-$233K-2.2%	-$228K

Metric	Q4'2210-K	Q3'2210-Q	Q2'2210-Q	Q1'2210-Q	Q4'2110-K	Q3'2110-Q	Q2'2110-Q	Q1'2110-Q
Operating Cash Flow	$210K+138.9%	-$220K+70.8%	-$1.4M-1242.6%	$78K-66.7%	-$540K+49.2%	-$753K-527.5%	-$108K+90.9%	$234K+127.8%
Depreciation & Amortization	$20K+33.3%	$22K-26.7%	$22K-31.3%	$36K+9.1%	$15K-28.6%	$30K-14.3%	$32K-3.0%	$33K-5.7%
Capital Expenditures	N/A	N/A	N/A	N/A	$19K-29.6%	$4K-50.0%	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	-$559K+48.7%	-$757K-491.4%	N/A	N/A
Investing Cash Flow	-$13K+31.6%	-$18K-350.0%	-$20K+25.9%	-$4K+88.9%	-$19K+32.1%	-$4K+69.2%	-$27K+81.3%	-$36K-500.0%
Financing Cash Flow	-$285K-150.7%	$44K-93.6%	$1.7M+306.9%	-$238K-12.8%	$562K-48.2%	$684K+366.1%	$423K-75.4%	-$211K-159.4%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

BDRL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BDRL quarterly financial ratios

Metric	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Gross Margin	30.2%-7.0pp	37.2%+18.8pp	18.4%+1.1pp	17.3%-21.5pp	38.8%+0.4pp	38.4%+1.2pp	37.1%+17.3pp	19.8%-17.8pp	37.6%+4.2pp	33.4%+0.7pp	32.7%-3.1pp	35.8%-4.4pp	40.2%
Operating Margin	-11.8%+7.0pp	-18.8%+24.6pp	-43.4%-41.1pp	-2.4%+1.6pp	-3.9%-5.9pp	2.0%+5.0pp	-3.0%+27.6pp	-30.6%-28.4pp	-2.2%+7.0pp	-9.1%-1.0pp	-8.1%-7.3pp	-0.9%-7.4pp	6.5%
Net Margin	-16.1%-16.7pp	0.5%+46.2pp	-45.6%-41.9pp	-3.7%+2.4pp	-6.2%-4.5pp	-1.7%+3.7pp	-5.3%+27.0pp	-32.3%-29.2pp	-3.1%+7.0pp	-10.1%+6.7pp	-16.8%-15.3pp	-1.5%-7.4pp	5.9%
Return on Equity	-271.9%-274.4pp	2.6%+606.8pp	-604.2%-594.1pp	-10.1%+8.6pp	-18.7%-13.5pp	-5.2%+13.1pp	-18.3%+73.6pp	-91.9%-85.3pp	-6.6%+12.2pp	-18.8%+12.2pp	-31.0%-29.1pp	-1.9%-10.0pp	8.1%
Return on Assets	-19.5%-20.2pp	0.7%+67.9pp	-67.2%-63.1pp	-4.0%+4.5pp	-8.6%-6.0pp	-2.5%+5.4pp	-8.0%+33.8pp	-41.7%-37.5pp	-4.3%+8.2pp	-12.5%+7.1pp	-19.6%-18.0pp	-1.6%-8.3pp	6.7%
Current Ratio	0.98-0.3x	1.27+0.2x	1.10-0.4x	1.45+0.2x	1.26-1.0x	2.27+0.5x	1.75+0.8x	0.96-2.3x	3.30-0.3x	3.60+0.7x	2.91-4.5x	7.41-0.8x	8.18
Debt-to-Equity	12.97+10.3x	2.63+1.2x	1.45+1.4x	0.010.0x	0.00-0.4x	0.42-0.1x	0.51+0.5x	0.00-0.3x	0.260.0x	0.260.0x	0.25+0.1x	0.130.0x	0.13
Asset Turnover	1.21-0.1x	1.32-0.1x	1.47+0.4x	1.08-0.3x	1.39-0.1x	1.530.0x	1.50+0.2x	1.29-0.1x	1.37+0.1x	1.23+0.1x	1.17+0.1x	1.03-0.1x	1.15
FCF Margin	N/A	-7.6%+13.0pp	-20.6%+13.7pp	-34.3%-36.6pp	2.3%+3.9pp	-1.6%-4.9pp	3.3%+8.0pp	-4.7%-7.9pp	3.2%-2.9pp	6.1%-5.4pp	11.6%+11.4pp	0.1%-9.5pp	9.7%

Metric	Q4'2210-K	Q3'2210-Q	Q2'2210-Q	Q1'2210-Q	Q4'2110-K	Q3'2110-Q	Q2'2110-Q	Q1'2110-Q
Gross Margin	39.0%+4.7pp	26.8%-9.2pp	25.0%-12.0pp	28.1%-14.5pp	34.3%+22.8pp	35.9%+18.3pp	37.0%+4.8pp	42.6%+28.9pp
Operating Margin	N/A	-9.0%+7.8pp	-22.7%-8.5pp	N/A	-19.5%+33.8pp	-16.9%+23.5pp	-14.2%+14.7pp	-26.6%+23.3pp
Net Margin	1.7%+24.9pp	-13.4%-8.5pp	-27.2%-64.7pp	-34.5%-21.8pp	-23.2%+32.6pp	-4.8%+38.0pp	37.5%+68.7pp	-12.7%+38.6pp
Return on Equity	8.4%+36.6pp	-75.0%-69.7pp	-78.5%-125.1pp	-47.9%-20.4pp	-28.2%+166.8pp	-5.3%+63.0pp	46.6%+74.4pp	-27.5%+11.0pp
Return on Assets	0.6%+8.4pp	-4.6%-2.9pp	-9.4%-23.0pp	-10.0%-6.3pp	-7.8%+13.9pp	-1.7%+11.5pp	13.7%+20.8pp	-3.7%+8.8pp
Current Ratio	0.98-0.3x	0.97-0.4x	0.99-0.3x	1.11-0.2x	1.27+0.2x	1.350.0x	1.29-0.2x	1.28+0.1x
Debt-to-Equity	12.97+10.3x	15.31+13.1x	7.38+5.0x	3.78-2.6x	2.63+1.2x	2.23-1.9x	2.41-0.5x	6.39+6.4x
Asset Turnover	0.350.0x	0.340.0x	0.340.0x	0.290.0x	0.34-0.1x	0.340.0x	0.36+0.1x	0.290.0x
FCF Margin	N/A	N/A	N/A	N/A	-14.0%+11.2pp	-18.1%-15.1pp	N/A	N/A

Note: The current ratio is below 1.0 (0.98), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
BLONDER TONGUE LABS INC BDRL	FY2022	$18.1M	-$2.9M	-16.1%	$260K	—
METALERT INC MLRT	FY2024	$181K	-$828K	N/A	$185K	—

Where BLONDER TONGUE LABS INC Ranks

Frequently Asked Questions

What is BLONDER TONGUE LABS INC's annual revenue?

BLONDER TONGUE LABS INC (BDRL) reported $18.1M in total revenue for fiscal year 2022. This represents a 15.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BLONDER TONGUE LABS INC's revenue growing?

BLONDER TONGUE LABS INC (BDRL) revenue grew by 15.0% year-over-year, from $15.8M to $18.1M in fiscal year 2022.

Is BLONDER TONGUE LABS INC profitable?

No, BLONDER TONGUE LABS INC (BDRL) reported a net income of -$2.9M in fiscal year 2022, with a net profit margin of -16.1%.

What is BLONDER TONGUE LABS INC's EBITDA?

BLONDER TONGUE LABS INC (BDRL) had EBITDA of -$2.0M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.

What is BLONDER TONGUE LABS INC's gross margin?

BLONDER TONGUE LABS INC (BDRL) had a gross margin of 30.2% in fiscal year 2022, indicating the percentage of revenue retained after direct costs of goods sold.

What is BLONDER TONGUE LABS INC's operating margin?

BLONDER TONGUE LABS INC (BDRL) had an operating margin of -11.8% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.

What is BLONDER TONGUE LABS INC's net profit margin?

BLONDER TONGUE LABS INC (BDRL) had a net profit margin of -16.1% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.

What is BLONDER TONGUE LABS INC's return on equity (ROE)?

BLONDER TONGUE LABS INC (BDRL) has a return on equity of -271.9% for fiscal year 2022, measuring how efficiently the company generates profit from shareholder equity.

What is BLONDER TONGUE LABS INC's operating cash flow?

BLONDER TONGUE LABS INC (BDRL) recorded an outflow of $1.4M in operating cash flow during fiscal year 2022, representing cash used by core business activities.

What are BLONDER TONGUE LABS INC's total assets?

BLONDER TONGUE LABS INC (BDRL) had $15.0M in total assets as of fiscal year 2022, including both current and long-term assets.

How much does BLONDER TONGUE LABS INC spend on research and development?

BLONDER TONGUE LABS INC (BDRL) invested $1.8M in research and development during fiscal year 2022.

How many shares does BLONDER TONGUE LABS INC have outstanding?

BLONDER TONGUE LABS INC (BDRL) had 13M shares outstanding as of fiscal year 2022.

What is BLONDER TONGUE LABS INC's current ratio?

BLONDER TONGUE LABS INC (BDRL) had a current ratio of 0.98 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.

What is BLONDER TONGUE LABS INC's debt-to-equity ratio?

BLONDER TONGUE LABS INC (BDRL) had a debt-to-equity ratio of 12.97 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is BLONDER TONGUE LABS INC's return on assets (ROA)?

BLONDER TONGUE LABS INC (BDRL) had a return on assets of -19.5% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.

How does BLONDER TONGUE LABS INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2022, BLONDER TONGUE LABS INC (BDRL) held $79K in cash, cash equivalents and investments, and reported an operating cash outflow of $1.4M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is BLONDER TONGUE LABS INC's Altman Z-Score?

BLONDER TONGUE LABS INC (BDRL) has an Altman Z-Score of -2.09, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is BLONDER TONGUE LABS INC's Piotroski F-Score?

BLONDER TONGUE LABS INC (BDRL) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are BLONDER TONGUE LABS INC's earnings high quality?

BLONDER TONGUE LABS INC (BDRL) reported a net loss of $2.9M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can BLONDER TONGUE LABS INC cover its interest payments?

BLONDER TONGUE LABS INC (BDRL) reported an operating loss of $2.1M against $789K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.